Increasing the value
and impact of clinical research

Annual Conference 2013, London
Tuesday 15th October, register your interest


Increasing the value and impact of clinical research

New models for the value-based pricing of pharmaceuticals are actively in development. Decision-makers in healthcare are increasingly using the highest quality scientific evidence to support clinical and health policy choices. It is imperative, more so than ever before, that everyone engaged in the design, conduct and analysis of clinical research focuses on the incorporation of measures that enhance its value and impact.

This conference brings together experts from across the UK’s clinical research community to explore the mechanisms by which this may be achieved.

The agenda and speakers will be announced shortly. Keep updated on the progress by following Events4Health on twitter.

The Annual Conference Agenda

09.00 - 09.30 Registration and coffee
09.30 - 09.35 Welcome Remarks
Professor Sir Gordon Duff, Chairman of the UK’s Commission on Human Medicine (CHM)
09.35 - 10.00 Key Note Speech
The value and impact of clinical research to healthcare: Past achievements, future potential
Professor Sir John Tooke, President of the Academy of Medical Sciences
10.00 - 11.20 Session 1: Commercial R&D Partnerships
The industry/NHS clinical research “health-check”
Dr Louise Wood, Deputy Director/Head of NHS Research Infrastructure and Growth, Research and Development Directorate at the Department of Health
Mark Samuels, Managing Director,  NIHR Office for Clinical Research Infrastructure (NOCRI)
Dr Clare Morgan, Performance and Industry Director, NIHR CRN

Working with Industry; The view from the Medical Research Council
Professor Sir John Savill, Chief Executive of the MRC
11.20 - 11.45 Coffee & Networking in Exhibition Area
11.45 - 13.15 Session 2: Enhancing patient involvement in clinical trials
The patient's view
Simon Denegri, Chair, INVOLVE

Best practices from top trusts
Heidi Neild and Simon Bourne, University Hospital Southampton
Dr Martina Prude, University of Southampton
Professor Steve Smye, R & D Director for the Leeds Teaching Hospital NHS Trust
Professor John Goodacre, CLRN Clinical Director
Helen Quinn, Senior Manger Peninsula Comprehensive Local Research Network

The oncology experience
Eric Low, Myeloma UK
Dr Sheila Fisher, NCRI / NCRN
13.15 - 14.00 Lunch & Networking in Exhibition Area
14.00 - 15.20 Session 3: The assessment of value in clinical research
Value-based pricing; What is it and where is it at?
Speaker TBC

How does society weight health benefits?
Professor Karl Claxton, Professor of Economics, University of York

What do rare diseases tell us about value assessment?
Josie Godfrey, Advisory Group for National Specialised Services

What new value measures are needed in clinical research to assist decision-makers?
Professor Ken Paterson, University of Glasgow
15.20 - 15.45 Coffee & Networking in Exhibition Area
15.45 - 16.45 Session 4: Ensuring enabling regulation
Progressing the work of the Health Research Authority
Joan Kirkbride, Director of Operations, NRES, HRA

How regulation can keep pace with innovation
Rebecca Stanbrook, Group Manager, Inspections (GCP/GPvP/GLP)
16.45 - 17.00 Summary Comments and Wrap Up
Professor Sir Gordon Duff, Chairman of the UK’s Commission on Human Medicine (CHM)

Download Agenda here.

Supporting Organisations

Sponsors Southampton University logo Iron Recruitment Cranfield University

Media Partners

media partners logos Pharma Times Pharmiweb logo Medical News today InPharm logo